20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2381 | Abemaciclib | CDK4/6 dual inhibitor,LY2835219 | CDK |
Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer. | |||
T1811 | WH-4-023 | KIN112,KIN001-112,Dual LCK/SRC inhibitor | Src |
WH-4-023 (Dual LCK/SRC inhibitor) is a potent and orally active Lck/Src inhibitor. It also potently inhibits SIK. | |||
T2431 | ID-8 | ID8 | DYRK |
ID-8, a DYRK inhibitor, sustains embryonic stem cell self-renewal in long-term culture. | |||
T5093 | Pim1/AKK1-IN-1 | LKB1/AAK1 dual inhibitor,MDK-2275 | Pim , Hippo pathway |
Pim1/AKK1-IN-1 (LKB1/AAK1 dual inhibitor) is a potent multi-kinase inhibitor with Kd values of 35 nM/53 nM/75 nM/380 nM for Pim1/AKK1/MST2/LKB1 respectively, and also inhibits MPSK1 and TNIK. | |||
T6257 | AZ191 | DYRK | |
AZ191(IC50 of 17 nM) is an effective and specific DYRK1B inhibitor. The specificity of AZ191 for DYRK1B is about 5- and 110-fold greater over DYRK1A and DYRK2, respectively. | |||
T15422 | GSK-626616 | DYRK | |
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia. | |||
TQ0111 | LDN-192960 | DYRK , Haspin Kinase | |
LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM). | |||
T1711 | Harmine | Telepathine | MAO , 5-HT Receptor , DYRK |
Harmine (Telepathine) is an alkaloid isolated from seeds of Peganum harmala. | |||
T7323 | BCI-215 | Phosphatase | |
BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling | |||
T11447 | GNF4877 | GSK-3 , DYRK | |
GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It leads to blockade of nuclear factor of activated T-cells (NFATc) nuclear export and increased β-cell proliferation cells. | |||
T40187 | GNF2133 | DYRK | |
GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 can be used in studies about type 1 diabetes. | |||
T2811 | Harmine hydrochloride | telepathine hydrochloride | 5-HT Receptor , DYRK , GluR |
Harmine hydrochloride (telepathine hydrochloride) is extracted from Peganum Harmala Genus. | |||
T14980 | CLK-IN-T3 | DYRK , CDK | |
CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity. | |||
T4199 | Desmethyl-VS-5584 | PI3K , mTOR | |
Desmethyl-VS-5584 is a dimethyl analog of VS-5584, which is a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer. | |||
T10616 | BRM/BRG1 ATP Inhibitor-1 | Epigenetic Reader Domain | |
BRM/BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM)/SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1/SMARCA4 ATPase activity inhibitor (IC50... | |||
T4584 | BMS-813160 | BMS 813160 | CCR |
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular. | |||
T14364 | AZ-Dyrk1B-33 | 3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine | DYRK |
AZ-Dyrk1B-33 (3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine) is a potent and selective Dyrk1B kinase inhibitor with an IC50 of 7 nM. | |||
T3707 | GNE-3511 | GNE3511 | DNA Alkylation , MAPK |
GNE-3511 is a potent and selective dual leucine zipper kinase inhibitors. | |||
T8409 | SYN1143 | RON-IN-1,AMG-1 | c-Met/HGFR |
SYN1143 (AMG-1) is a potent inhibitor of human RON and c-Met.In vitro kinase assays showed that compound I is a potent inhibitor of human RON and c-Met with IC50s of 9 and 4 nmol/L, respectively. | |||
T4636 | Protein kinase inhibitors 1 | Others , DYRK | |
Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM. |